LANDOS BIOPHARMA INC (LABP)

US5150692011 - Common Stock

22.31  -0.18 (-0.8%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.0018.00M0.000.00
Operating Expenses
22.73M40.26M56.82M30.68M13.29M
Research and Development
12.00M25.68M41.56M25.34M11.81M
Selling, General, and Administrative Expenses
10.73M14.58M15.25M5.34M1.48M
Operating Income
-22.73M-40.26M-38.82M-30.68M-13.29M
Interest Income/Expense
-44.00K30.00K-20.00K80.00K-340.00K
Other Income/Expense
836.00K1.26M410.00K460.00K160.00K
Non Recurring Items
N/A-300.00KN/AN/AN/A
Income Before Taxes
-21.93M-39.28M-38.42M-30.14M-13.47M
Net Income
-21.93M-39.28M-38.42M-30.14M-13.47M
EBITDA
N/A-39.68M-38.62M-30.54M-13.19M
 
Per Share Data
EPS Diluted Total Ops
-3.50-9.76-10.23-7.51-3.44
Non GAAP EPS
-3.46-9.80N/AN/AN/A
 
Statistics
Profit Margin
N/AN/A-213.44%N/AN/A
Operating Profit Margin
N/AN/A-215.67%N/AN/A

All data in USD

Charts